351 related articles for article (PubMed ID: 25003671)
1. Role of gut microbiota: obesity and NAFLD.
Gangarapu V; Yıldız K; Ince AT; Baysal B
Turk J Gastroenterol; 2014 Apr; 25(2):133-40. PubMed ID: 25003671
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
3. Obesity, fatty liver disease and intestinal microbiota.
Arslan N
World J Gastroenterol; 2014 Nov; 20(44):16452-63. PubMed ID: 25469013
[TBL] [Abstract][Full Text] [Related]
4. Obesity and NAFLD: the role of bacteria and microbiota.
Duseja A; Chawla YK
Clin Liver Dis; 2014 Feb; 18(1):59-71. PubMed ID: 24274865
[TBL] [Abstract][Full Text] [Related]
5. Microbiota, Obesity and NAFLD.
Lau LHS; Wong SH
Adv Exp Med Biol; 2018; 1061():111-125. PubMed ID: 29956210
[TBL] [Abstract][Full Text] [Related]
6. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.
Kirpich IA; Marsano LS; McClain CJ
Clin Biochem; 2015 Sep; 48(13-14):923-30. PubMed ID: 26151226
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an
Carbajo-Pescador S; Porras D; García-Mediavilla MV; Martínez-Flórez S; Juarez-Fernández M; Cuevas MJ; Mauriz JL; González-Gallego J; Nistal E; Sánchez-Campos S
Dis Model Mech; 2019 Apr; 12(5):. PubMed ID: 30971408
[TBL] [Abstract][Full Text] [Related]
8. Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease.
Miura K; Ohnishi H
World J Gastroenterol; 2014 Jun; 20(23):7381-91. PubMed ID: 24966608
[TBL] [Abstract][Full Text] [Related]
9. Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.
Paolella G; Mandato C; Pierri L; Poeta M; Di Stasi M; Vajro P
World J Gastroenterol; 2014 Nov; 20(42):15518-31. PubMed ID: 25400436
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiome and nonalcoholic fatty liver diseases.
Zhu L; Baker RD; Baker SS
Pediatr Res; 2015 Jan; 77(1-2):245-51. PubMed ID: 25310763
[TBL] [Abstract][Full Text] [Related]
11. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.
Jiang C; Xie C; Li F; Zhang L; Nichols RG; Krausz KW; Cai J; Qi Y; Fang ZZ; Takahashi S; Tanaka N; Desai D; Amin SG; Albert I; Patterson AD; Gonzalez FJ
J Clin Invest; 2015 Jan; 125(1):386-402. PubMed ID: 25500885
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
[TBL] [Abstract][Full Text] [Related]
13. Intestinal hormones, gut microbiota and non-alcoholic fatty liver disease.
Koukias N; Buzzetti E; Tsochatzis EA
Minerva Endocrinol; 2017 Jun; 42(2):184-194. PubMed ID: 27879962
[TBL] [Abstract][Full Text] [Related]
14. The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease.
Ferolla SM; Armiliato GN; Couto CA; Ferrari TC
Nutrients; 2014 Dec; 6(12):5583-99. PubMed ID: 25479248
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics.
He X; Ji G; Jia W; Li H
Int J Mol Sci; 2016 Mar; 17(3):300. PubMed ID: 26999104
[TBL] [Abstract][Full Text] [Related]
16. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice.
Porras D; Nistal E; Martínez-Flórez S; Olcoz JL; Jover R; Jorquera F; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Mol Nutr Food Res; 2019 Apr; 63(8):e1800930. PubMed ID: 30680920
[TBL] [Abstract][Full Text] [Related]
17. [Not Available].
Buffet C
Bull Acad Natl Med; 2014 Dec; 198(9):1641-52. PubMed ID: 27356366
[TBL] [Abstract][Full Text] [Related]
18. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes.
Musso G; Gambino R; Cassader M
Annu Rev Med; 2011; 62():361-80. PubMed ID: 21226616
[TBL] [Abstract][Full Text] [Related]
19. Intestinal microbiota and obesity.
Blaut M; Klaus S
Handb Exp Pharmacol; 2012; (209):251-73. PubMed ID: 22249818
[TBL] [Abstract][Full Text] [Related]
20. Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet.
Machado MV; Cortez-Pinto H
Int J Mol Sci; 2016 Apr; 17(4):481. PubMed ID: 27043550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]